Dudediligence.

BioMarin Pharmaceutical Inc

BMRNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$745.7MSep ’24$747.3MDec ’24$745.1MMar ’25$825.4MJun ’25$776.1MSep ’25$874.6MDec ’25$766.2MMar ’26$989.7MJun ’26
Net income, by quarter
$106.1MSep ’24$124.9MDec ’24$185.7MMar ’25$240.5MJun ’25−$30.7MSep ’25−$46.6MDec ’25$105.5MMar ’26$44.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.85B$2.10B$2.42B$2.85B$3.22B
Gross profit$1.38B$1.59B$1.89B$2.27B$2.50B
Operating income−$82.3M$161.0M$185.8M$484.2M$409.5M
Net income−$64.1M$141.6M$167.6M$426.9M$348.9M
Operating cash flow$304.5M$175.9M$159.3M$572.8M$828.0M
Free cash flow$209.0M$54.9M$62.6M$487.4M$725.0M
Cash$587.3M$724.5M$755.1M$942.8M$1.31B
Debtnone on filenone on filenone on filenone on file$597.2M
Shares outstanding183.9M186.3M188.6M190.8M192.3M